Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

chemotherapy

  • [<sup>177</sup>Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
    You have access
    [177Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Metaanalysis
    Swayamjeet Satapathy, Ranjit K. Sahoo and Chandrasekhar Bal
    Journal of Nuclear Medicine August 1, 2023, 64 (8) 1266-1271; DOI: https://doi.org/10.2967/jnumed.123.265414
  • <sup>68</sup>Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    You have access
    68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy
    Qaid Ahmed Shagera, Carlos Artigas, Ioannis Karfis, Gabriela Critchi, Nieves Martinez Chanza, Spyridon Sideris, Alexandre Peltier, Marianne Paesmans, Thierry Gil and Patrick Flamen
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1191-1198; DOI: https://doi.org/10.2967/jnumed.121.263006
  • You have access
    18F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy
    Jelena Levi, Samuel Goth, Lyna Huynh, Tina Lam, Tony L. Huynh, Brailee Schulte and Juliet A. Packiasamy
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 802-807; DOI: https://doi.org/10.2967/jnumed.120.249078
  • You have access
    Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective Study
    Arnoldo Piccardo, Giovanni Morana, Matteo Puntoni, Sara Campora, Stefania Sorrentino, Pietro Zucchetta, Martina Ugolini, Massimo Conte, Angelina Cistaro, Giulia Ferrarazzo, Marco Pescetto, Marco Lattuada, Gianluca Bottoni, Alberto Garaventa, Luca Giovanella and Egesta Lopci
    Journal of Nuclear Medicine March 1, 2020, 61 (3) 367-374; DOI: https://doi.org/10.2967/jnumed.119.232553
  • You have access
    Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury
    April Alcantara, Gholam R. Berenji, Carole S. Scherling, Beata Durcanova, Daniel Diaz-Aguilar and Daniel H.S. Silverman
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1682-1690; DOI: https://doi.org/10.2967/jnumed.119.237578
  • You have access
    Clinical Outcomes of 177Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy
    Thomas W. Barber, Aviral Singh, Harshad R. Kulkarni, Karin Niepsch, Baki Billah and Richard P. Baum
    Journal of Nuclear Medicine July 1, 2019, 60 (7) 955-962; DOI: https://doi.org/10.2967/jnumed.118.216820
  • You have access
    Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication
    Seongyeol Park, Seunggyun Ha, Hyun Woo Kwon, Woo Hyoung Kim, Tae-Yong Kim, Do-Youn Oh, Gi Jeong Cheon and Yung-Jue Bang
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 899-904; DOI: https://doi.org/10.2967/jnumed.116.182675
  • You have access
    Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin
    Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens and Leonie Wyffels
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 805-811; DOI: https://doi.org/10.2967/jnumed.115.168344
  • You have access
    Postchemotherapy and Tumor-Selective Targeting with the La-Specific DAB4 Monoclonal Antibody Relates to Apoptotic Cell Clearance
    Fares Al-Ejeh, Alexander H. Staudacher, Douglas R. Smyth, Jocelyn M. Darby, Delphine Denoyer, Chris Tsopelas, Rodney J. Hicks and Michael P. Brown
    Journal of Nuclear Medicine May 1, 2014, 55 (5) 772-779; DOI: https://doi.org/10.2967/jnumed.113.130559
  • You have access
    Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine
    Rebecca A. Herbertson, Niall C. Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell, Tina Cavicchiolo, Tim Saunder, Graeme J. O’Keefe, Aurora Poon, Sze Ting Lee, Roger Murphy, Wendie Hopkins, Fiona E. Scott and Andrew M. Scott
    Journal of Nuclear Medicine April 1, 2014, 55 (4) 534-539; DOI: https://doi.org/10.2967/jnumed.113.132761

Pages

  • Next
  • 1
  • 2
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire